Skip to main content
Clinical Trials/NCT03000972
NCT03000972
Completed
Not Applicable

PFN-A Intramedullary Nail and Intertrochanteric Hip Fracture. Augmentation of the Femoral Head Assessed by PET-CT (Positron Emission Tomography - Computed Tomography)- a Randomized Trial

Uppsala University1 site in 1 country20 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intertrochanteric Fracture
Sponsor
Uppsala University
Enrollment
20
Locations
1
Primary Endpoint
Viability of the femoral head as assessed by fluoride uptake using PET-CT
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study evaluates the potential negative effect of cement augmentation in the femoral head on viability of the head. Half of the participants will have the standard intramedullary nail (PFN-A; Proximal Femoral Nail Augmentation), while the other half will get the standard nail plus cement augmentation.

Detailed Description

Cement augmentation is believed to increase the bone implant interface and therefore decrease the risk of implant cut-out of the femoral head. The cement used in previous studies has produced heat and thermal necrosis on bone cells. The cement used in this study (TraumaCemV+) is manufactured specially for this implant and for the augmentation of this implant. TraumaCemV sets under low temperature (40 degrees Celsius) and we do not anticipate any heat necrosis. The volume effect of the cement could theoretically also damage the blood flow in the femoral head. There have been no negative effects in big series of patients operated with this technique. The aim of this study is to quantify the viability of the femoral head with the use PET-CT (Positron Emission Tomography with simultaneous Computed Tomography) including a radioactive isotope (Fluorine-18) and the use of threedimensional computed tomography.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
October 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Uppsala University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Intertrochanteric Hip Fracture AO (Arbeitsgemeinschaft für Osteosynthesefragen) 31-A1 or AO 31-A2
  • Healthy contralateral hip
  • ASA (American Society of Anesthesiologists) Physical Status Class I or II

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Viability of the femoral head as assessed by fluoride uptake using PET-CT

Time Frame: 4 months postoperatively

The primary endpoint is the level of fluoride uptake (standardized uptake values: SUVs) representing bone metabolism. PET-CT enables us to quantify this tridimensionally.

Secondary Outcomes

  • Harris Hip Score(1 year)
  • Viability of the femoral head as assessed by fluoride uptake using PET-CT(1 year postoperatively)

Study Sites (1)

Loading locations...

Similar Trials